Losartan Potassium Tablets

SECTION 2: Hazards identification

Appearance: White Tablets

Signal word

WARNING

Hazard statements

Suspected of damaging the unborn child.

Additional information

Short Term: Antihypertensive drug: has blood pressure-lowering properties Long Term: Based on its pharmacologic properties and findings in animal studies, this compound may cause the use of this drugs may cause fetal and neonatal toxicity, including low blood pressure and kidney failure, when they are taken during the second and third trimesters of pregnancy. Known Clinical Effects: Adverse effects associated with therapeutic use include dizziness, headache, lethargy, changes in blood pressure, nausea, abdominal pain, hypersensitivity reactions, impaired renal function, and potential liver toxicity in people with impaired liver function. EU Indication of danger: Toxic to Reproduction: Category 3 EU Hazard Symbols: EU Risk Phrases: R63 - Possible risk of harm to the unborn child. Australian Hazard Classification

Hazardous Ingredients

Non-Dangerous Goods (NOHSC): Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.